Cyclooxygenase inhibitors induce apoptosis in sinonasal cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene

International Journal of Cancer

Volumn 122, Issue 8, 2008, Pages 1765-1773

  Jeong, Hong Kim ^a   Jung, Hyun Chang ^b   Rhee, Kwang Hyeon ^c   Yoon, Joo Heon ^c   Soon, Ho Kwon ^c   Song, Keejae ^c   Kun, Wayn Lee ^c   Chang, Il Cho ^c   Ju, Hyun Jeon ^c   Kim, Kyung Su ^c,d  

^a Jeju National University School of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Chemoprevention; NAG 1; NSAIDs; Sinonasal cancer

Indexed keywords

ACECLOFENAC; DICLOFENAC; INDOMETACIN; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; SMALL INTERFERING RNA; SULINDAC SULFIDE; ANTINEOPLASTIC AGENT; CYTOKINE; GROWTH DIFFERENTIATION FACTOR 15; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SAFETY; EPITHELIUM CELL; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NONSTEROIDAL ANTIINFLAMMATORY DRUG ACTIVATED GENE; NOSE CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINONASAL CANCER; TUMOR; XENOGRAFT; ANIMAL; CARCINOMA; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; NUDE MOUSE; PARANASAL SINUS TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TUMOR CELL LINE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE INHIBITORS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOMETHACIN; MICE; MICE, NUDE; PARANASAL SINUS NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 40349114539     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23302     Document Type: Article

References (33)

1. Half EE, Arber N. Chemoprevention of colorectal cancer: two steps forward, one step back? Future Oncol 2006;2:697-704.
2. Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 2000;60:293-7.
3. Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE. Cyclooxygenase inhibitors regulate the expression of a TGF-β superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 2001;59:901-8.
4. Baek SJ, Wilson LC, Lee CH, Eling TE. Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene. J Pharmacol Exp Ther 2002;301:1126-31.
5. Kim KS, Baek SJ, Flake GP, Loftin CD, Calvo BF, Eling TE. Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue. Gastroenterology 2002;305:1388-98.
6. Kim KS, Yoon JH, Kim JK, Baek SJ, Eling TE, Lee WJ, Ryu JH, Lee JG, Lee JH, Yoo JB. Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene. Biochem Biophys Res Commun 2004;325:1298-303.
7. Kim JS, Baek SJ, Sali T, Eling TE. The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1/MIC-1/GDF-15. Mol Cancer Ther 2005;4:487-93.
8. Shim M, Eling TE. Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells. J Biol Chem 2005;280:18636-42.
9. Baek SJ, Wilson LC, Eling TE. Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis 2002;23:425-32.
10. Wilson LC, Baek SJ, Call A, Eling TE. Non-steroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int J Cancer 2003;105:747-53.
11. Newman D, Sakaue M, Koo JS, Kim KS, Baek SJ, Eling TE, Jetten AM. Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids. Mol Pharmacol 2003;63:557-64.
12. Lee SH, Kim JS, Yamaguchi K, Eling TE, Baek SJ. Indole-3-carbinol and 3,3′-diindolylmethan induce expression of NAG-1 in a p53-independent manner. Biochem Biophys Res Commun 2005;328:63-9.
13. Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE. Expression of NAG-1, a transforming growth factor-β superfamily member, by troglitazone requires the early growth response gene EGR-1. J Biol Chem 2004;279:6883-92.
14. Yamaguchi K, Lee SH, Eling TE, Baek SJ. A novel peroxisome proliferator-activated receptor gamma ligand, MCC-555, induces apoptosis via posttranscriptional regulation of NAG-1 in colorectal cancer cells. Mol Cancer Ther 2006;5:1352-61.
15. Lee SH, Yamaguchi K, Kim JS, Eling TE, Safe S, Park Y, Baek SJ. Conjugated linoleic acid stimulates an antitumorigenic protein NAG-1 in an isomer specific manner. Carcinogenesis 2006;27:972-81.
16. Kim CH, Song KS, Kim KS, Kim JY, Lee BJ, Lee JG, Yoon JH. Sulindac sulfide-induced apoptosis in sinonasal cancer cells. Acta Otolaryngol 2005;125:201-6.
17. Fan GK, Imanaka M, Yang B, Takenaka H. Characteristics of nasal inverted papilloma and its malignant transformation: a study of cell proliferation and programmed cell death. Am J Rhinol 2006;20:360-3.
18. Katori H, Nozawa A, Tsukuda M. Increased expression of matrix metalloproteinae-2 and 9 and human papilloma virus infection are associated with malignant transformation of sinonasal inverted papilloma. J Surg Oncol 2006;93:80-5.
19. Katori H, Nozawa A, Tsukuda M. Markers of malignant transformation of sinonasal inverted papilloma. Eur J Surg Oncol 2005;31:905-11.
20. Kim KS, Shin JH, Baek SJ, Yoon JH. Expression of non-steroidal anti-inflammatory drug-activated gene-1 in human nasal mucosa and cultured nasal epithelial cells: a preliminary investigation. Acta Otolaryngol 2003;123:857-61.
21. Eling TE, Baek SJ, Shim M, Lee CH. NSAID activated gene (NAG-1), a modulator of tumorigenesis. J Biochem Mol Biol 2006;39:649-55.
22. Baek SJ, Eling TE. Changes in gene expression contribute to cancer prevention by COX inhibitors. Prog Lipid Res 2006;45:1-16.
23. Chan CC, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchsinson AW, Forrest MJ, Gauthier JY, Gordon R, Gresser M, et al. Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)- furonone]: a potent and orally active cyclooxygenase-2 inhibitor. pharmacological and biochemical profiles. J Pharmacol Exp Ther 1999;290:551-60.
24. Kato M, Nishida S, Kitasato H, Sakata N, Kawai S. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol 2001;52:1679-85.
25. Martinez JM, Sali T, Okazaki R, Anna C, Hollingshead M, Hose C, Monks A, Walker NJ, Baek SJ, Eling TE. Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene/macrophage inhibitory cytokine-1/prostate- derived factor, a putative tumor suppressor, inhibits tumor growth. J Pharmacol Exp Ther 2006;318:899-906.
26. Baek SJ, Okazaki R, Lee SH, Martinez J, Kim JS, Yamaguchi K, Mishina Y, Martin DW, Shoieb A, McEntee MF, Eling TE. Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 2006;131:1553-60.
27. Brown DA, Ward RL, Buckhaults P, Lie T, Romans KE, Hawkins NJ. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 2003;9:2642-50.
28. Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I, Lee JH. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Cancer Res 2003;63:4648-55.
29. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF, Hampton GM. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001;61:5974-8.
30. Alvan G, Orme M, Bertilsson L, Ekstrand R, Palmer L. Pharmacokinetics of indomethacin. Clin Pharmacol Ther 1975;18:364-73.
31. Duggan DE, Hogans AF, Kwan KC, McMahon FG. The metabolism of indomethacin in man. J Pharmacol Exp Ther 1972;181:563-75.
32. Skinhoj A, Bechgaard H, Chasseaud LF, Brodie RR, Sharman JM, Taylor T, Hunter JO. The influence of food and repeated dosing on the bioavailability of indomethacin from a multiple-units controlled-release formulation. Int J Clin Pharmacol Ther Toxicol 1984;22:557-61.
33. Kwan KC, Breault GO, Umbenhauer ER, McMahon FG, Duggan DE. Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man. J Pharmacokinet Biopharm 1976;4:255-80.